• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Will Cannabis Genetics Be Restricted?

The redefinition of hemp under federal law, scheduled to take effect Nov. 12, spells the loss of Farm Bill protections for numerous hemp-derived THC products across the country: mild beverages as well as THCA flower and delta-8 THC edibles, vapes and additional products sold at gas stations and smoke shops.

But the hemp prohibition also creates a significant complication for the legal cannabis sector. Seeds from cannabis varieties that produce flower with more than 0.3% THC are no longer legal to ship out of state.

Although seed buying will likely continue in legal states, the modifications threaten to shutter some seed banks and genetics companies, observers note, while creating supply-chain issues for cannabis growers and retailers.

"If this wording goes forward, we will need pop-up stores to sell seeds in every state where it's permitted," Campanella said. "Which is why we're also providing clones and tissue culture, because that's not covered in the bill."

When are cannabis genetics and clones illegal to ship across state lines?

The new regulations categorize seeds depending on the THC potential of the parent plant. Genetic material such as seeds and clones are rendered illegal if the final product crosses the threshold.

For the moment, https://nativesusa.com/) seeds are currently shipping under the 2018 Farm Bill's current quo. But the clock is ticking for enterprises like Brothers Grimm and for cannabis cultivators who fear supply chain interruptions if out-of-state availability to genetics is prohibited.

Most of the cannabis industry remains mostly unaware of the approaching shutdown of the interstate genetics marketplace, said Ryan Power, co-founder of Sebastopol, California-based company Atlas Seed.

Without federal intervention in the form of an exception for seeds or an overall moratorium, numerous seed suppliers will simply be shuttered by November, he added.

"We are functioning legally currently, but if that changes, it will upend the legitimate licensed industry in every state," said Power, whose customers includes seed banks as well as licensed commercial cultivators.

"Customers are going to forfeit choice, and it will be a major shutdown for most people."

What are cannabis seed suppliers doing to stay legal after the government hemp ban?

Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which tightened cannabis oversight in that state while also restricting hemp-derived THC items to licensed cannabis retailers.

Formerly a seed supplier, Silberhaze is currently focused on the marketing, preservation and IP safeguarding of elite plant genetics.

That's because seed businesses hoping to stay compliant in this updated environment must have airtight documentation, he said.

"You have to demonstrate where this stuff comes from, so it's very important to have records, even to the extent where you have cultivator names," Silber said.

"Small businesses will have to work with better records and a stronger chain of custody," he added. "We want that documentation too, because we don't want to be working with questionable sources."

To prevent seizures and additional legal fallout, seed entrepreneurs must "get their affairs in order" before the updated regulations take place, Silber said.

"Audit all your materials immediately, and categorize what you can," Silber said. "Take stock, document your heritage, preserve breeder records, and organize any cannabinoid or terpene information you already have. If regulations change, you'll be in a much better position to understand what may be affected and make informed decisions."

Does government marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration licensing may be necessary for businesses engaged in research.

But for now, seed houses can't register with the DEA like state-licensed therapeutic cannabis businesses can. Such a pathway is not available to seed suppliers, nurseries or genetics companies, said Jim Ickes, an attorney and partner with Frantz Ward's cannabis practice group in Cleveland.

"Seed-related activity may be occurring inside larger state-licensed medical marijuana businesses, as some states allow dispensaries or registered medical operators to sell seeds, clones or personal growing materials," he said.

"But that is distinct from the DEA establishing a freestanding seed supplier registration category."

Some genetics operators are already changing operational practices to conform with the updated law. According to Ickes, they must answer questions including:

• Which of our varieties produce plants above 0.3% total THC?
• Which seeds survive as hemp after Nov. 12, 2026, and which don't?
• What does our catalog look like once we sort it against the genetics exclusion?

Ickes also understands confusion from clients who believed federal rescheduling of therapeutic marijuana would clarify their story with banking institutions. However, the recent regulatory language has shifted those conversations beyond the fundamentals of classification, he said.

"Financial institutions ask whether this particular revenue source is lawful, whether it connects to state-licensed operations, or whether there's interstate-commerce risk," said Ickes.

"After November, a seed bank selling high-THC genetics can't address the initial question with the hemp classification. It has to point to a lawful state cannabis channel instead. Seed suppliers dealing in genuine industrial-hemp seed maintain the simpler story."

What's the future of cannabis genetics?

Campanella is a member of a emerging coalition of fellow breeders, growers and researchers that's arguing seeds are more appropriately defined as farm inputs than regulated substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, allowing the DEA to focus its enforcement efforts elsewhere.

"How do you regulate something based on what it could become later?" said Campanella. "Our preference is to have that language removed, or get seeds regulated by the USDA as a hemp product."

But in the meantime, Campanella is reorganizing Brothers Grimm to function outside the reach of shifting federal oversight. The business plans to maintain its Colorado seed operation while placing its Oklahoma tissue cultivation facility as a safeguard against government prohibition of cannabis seeds.

As she noted: "If things evolve in a way where we can't focus on interstate transport, we'll have other resources to meet people's requirements without putting ourselves in trouble."